The Psychiatric Laboratory & the Department of Psychiatry, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China.
Psychiatry Res. 2012 Dec 30;200(2-3):1047-50. doi: 10.1016/j.psychres.2012.06.024. Epub 2012 Jul 15.
The study analyzed the effect of dopamine 2 receptor gene (DRD2) polymorphism on the risk for major depressive disorder (MDD) and the response to selective serotonin reuptake inhibitors (SSRIs). The results suggest that the DRD2 gene may play a role on MDD susceptibility and the onset-time of antidepressant response.
该研究分析了多巴胺 2 受体基因(DRD2)多态性对重度抑郁症(MDD)发病风险和对选择性 5-羟色胺再摄取抑制剂(SSRIs)反应的影响。结果表明,DRD2 基因可能在 MDD 易感性和抗抑郁药反应的发病时间上发挥作用。